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Abstract
Background: Metabolic syndrome (MS) is associated with subsequent appearance of diabetes and cardiovascular
disease. As compared to other Spanish regions, Murcia (southern Spain) registers increased obesity as well as
cardiovascular morbidity and mortality. The aim of this study was to assess the prevalence of MS and its
components, awareness of obesity as a health risk and associated lifestyles.
Methods: A population-based, cross-sectional study was conducted in 2003, covering a sample of 1555 individuals
20 years and over. MS was defined according to the Revised National Cholesterol Education Program Adult
Treatment Panel III (R-ATPIII), International Diabetes Federation (IDF) and Joint Interim Statement (JIS) criteria. Both
low (94/80) and high (102/88) waist circumference (WC) thresholds were considered.
Results: Prevalence of MS was 27.2% (95%CI: 25.2-29.2), 32.2% (95%CI: 30.1-34.3) and 33.2% (95%CI: 31.2-35.3)
according to the R-ATPIII, IDF and JIS94/80 respectively. It increased with age until reaching 52.6% (R-ATPIII) or
60.3% (JIS94/80) among persons aged 70 years and over, and was higher in persons with little or no formal
education (51.7% R-ATPIII, 57.3% JIS94/80). The most common risk factors were hypertension (46.6%) and central
obesity (40.7% and 66.1% according to high and low WC cut-off points respectively). Although most persons were
aware that obesity increased health risks, regular exercise was very unusual (13.0% centrally obese, 27.2% non-
centrally obese). Adherence to dietary recommendations was similar among centrally obese and non-centrally
obese subjects.
Conclusions: Prevalence of MS is high in our population, is comparable to that found in northern Europe and
varies with the definition used. Adherence to preventive recommendations and to adequate weight promotion is
very low. In the absence of a specific treatment for MS, integrated intervention based on a sustained increase in
physical activity and changes in diet should be reinforced.
Background
Metabolic syndrome (MS), a cluster of metabolically
related cardiovascular risk factors, is associated with
increased risk of death, cardiovascular events or diabetes
[1]. Nowadays, estimates suggest that the population-
attributable fraction for MS is approximately 6%-7% for
all-cause mortality, 12%-17% for cardiovascular disease
and 30%-52% for diabetes, depending on the criteria
used [1]. Insulin resistance and central obesity seem to
be closely involved in its aetiology [2,3].
Although the Murcia Region registers low cardiovas-
cular mortality [4] and low incidence of acute myocar-
dial infarction [5] at a European level, its myocardial
infarction incidence and mortality rates are nevertheless
among the highest in Spain [5,6]. Prevalence of diabetes
in Murcia is considered to be at the upper limit of the
moderate diabetes prevalence range [7], despite a nota-
bly high adherence to the Mediterranean dietary pattern
and its components [8-10], something that has been
shown to have a beneficial effect on insulin sensitivity
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any medium, provided the original work is properly cited.[11]. Overweight and general obesity are very frequent
and affect two out of every three adults [12]. Abdominal
obesity is one of the highest recorded among European
populations [13].
Bearing in mind the important role of central obesity
in its appearance, a high prevalence of MS is expected
in the adult population of the Murcia Region, thus justi-
fying our interest in the matter. The main difficulty hin-
dering its assessment is the lack of consensus on a
definition. Currently, there are several definitions in
more or less widespread use. There are: a) the World
Health Organization definition [14] including a criterion
of albuminuria, hardly available in large population-
based surveys; b) the European Group for the Study of
Insulin Resistance definition [15] focusing on insulin
resistance with the expensive determination of insulinae-
mia; c) the revised National Cholesterol Education Pro-
gram Adult Treatment Panel III (R-ATPIII) definition
[16] and d) the International Diabetes Federation (IDF)
definition [3], focusing on central obesity and using dif-
ferent cut-off points for waist circumference with the
aim of being adaptable to different population. Recently,
the major organizations involved in the clinical charac-
terisation of MS (the IDF Task Force on Epidemiology
and Prevention, the National Heart, Lung and Blood
Institute, the American Heart Association, the World
Heart Federation, the International Atherosclerosis
Society and the International Association for the Study
of Obesity) attempted to unify criteria by issuing a Joint
Interim Statement (JIS)[17]. Accordingly, our study
sought to assess the prevalence of the MS according to
the R-ATPIII, IDF and JIS definitions, as well as the pre-
valence of each of its components, awareness of obesity
as a health risk, and associated lifestyles.
Methods
Study Population
Murcia, a Mediterranean area lying in the south-east of
Spain, is one of the 17 Autonomous Regions (comuni-
dades autónomas) into which the country is divided.
The framework for this study was the region’se n t i r e
adult population aged 20 years and over, a total of
901,920 persons (2001 Census). Two thousand, five hun-
dred and sixty-two subjects were selected by randomised
sampling, stratified by age, sex, health area and type of
residence (urban or rural), and invited to participate
from July 2001 to June 2003. Exclusion criteria were
pregnancy and/or any serious physical or mental disease.
Subjects were invited to a primary health care centre,
where they answered a lifestyle questionnaire adminis-
tered by trained interviewers, underwent a physical
examination, and provided a blood sample for biochem-
ical determinations including fasting plasma glucose,
HDL-cholesterol and triglycerides. Details on sampling,
study design, biochemical determinations and physical
examination have been published elsewhere [7]. The
study was approved by the Ethics Committee of the Vir-
gen de la Arrixaca University Teaching Hospital, the
main regional hospital, and all subjects gave their writ-
ten informed consent.
Lifestyle questionnaire
To assess awareness of the pathogenic role of obesity,
subjects were asked whether they considered it a dis-
e a s e ,b ya n s w e r i n gt h eq u e s t i o n s“In your opinion, is
obesity a disease?” and “Do you know that obesity is
associated with diabetes and heart attacks?” Questions
on leisure-time physical activity were based on a pre-
viously validated questionnaire [18]. The number of
hours of leisure-time physical activity per week was
recorded. The American College of Sports Medicine
and the American Heart Association recommend that
adults should do physical activity for a minimum of 30
minutes a day, five days a week, in order to promote
and maintain good health [19]. In line with these
recommendations, moderate to vigorous physical activ-
ity for two and a half hours per week was considered
adequate. Intake of the main dietary components (cer-
eals, fruit, vegetables, legumes, fish, red meat, olive oil
and wine) was measured using a food-frequency ques-
tionnaire. According to the Mediterranean diet pyra-
mid [20], using olive oil daily, eating cereals, fruit,
vegetables more than once daily, legumes and fish
more than once per week and red meat less than twice
per week was considered adequate. Insofar as alcohol
was concerned, wine consumption of one glass per
week to three per day for men and one glass per week
to one per day for women was deemed to be the
recommended moderate intake. Smoking was classified
as never, ex- and current smoker. Educational level
was defined as little or no formal education, primary,
secondary and university.
Physical examination
The participants underwent a physical examination, in
which weight and height were measured using a stadi-
ometer with an accuracy of 1 cm (Añó-Sayol model
1SB, Barcelona, Spain) and a digital scale with an accu-
racy of 100 g (TEFAL model SC-3301, GROUPE SEB
Iberica, S.A., Barcelona, Spain). Body mass index (BMI)
was calculated as weight divided by the square height, in
kg/m2. Additionally, waist and hip circumferences were
measured according to WHO recommendations [21].
Arterial blood pressure was measured according to the
MONICA protocol [22], using a digital sphygmoman-
ometer (BOSO oscillomat
®). Systolic and diastolic arter-
ial blood pressure was calculated as the mean of two
consecutive measures.
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glucose and diabetes
Participants were classified as having or not having MS
according to the R-ATPIII [16], IDF [3] and JIS defini-
tions. Under the R-ATPIII, a diagnosis of MS, requires
three or more of the following criteria: 1) central obe-
sity, defined as elevated waist circumference ≥102 cm
for males or ≥88 cm for females; 2) elevated triglycerides
≥150 mg/dL; 3) reduced HDL-cholesterol <40 mg/dL in
men or <50 mg/dL in women; 4) elevated blood pres-
sure ≥130/85 mmHg or use of an antihypertensive
agent; and 5) elevated fasting glucose ≥100 mg/dL or
previous diagnosis of diabetes or impaired glucose toler-
ance. Diagnosis of MS according to the IDF definition
requires the presence of abdominal obesity defined as
elevated waist circumference ≥94 cm among men or
≥80 cm among women for European populations,
together with at least two of the other four criteria of
the R-ATPIII definition using the same categorical cut-
off points. In much the same way, the JIS definition
requires the presence of at least three of the five compo-
nents and considers two levels of abdominal obesity for
European populations, namely: a high cut-off point
(102/88) for waist circumference proposed by European
Cardiovascular Societies[23]; and a low cut-off point
(94/80) as proposed by the IDF. As the JIS high cut-off
point definition is identical to the R-ATPIII definition,
only data for the JIS low cut-off point definition differ
from those for the other former definitions of MS. Indi-
viduals on antihypertensive, diabetes and/or lipid-lower-
ing medication were included in the elevated blood
pressure, elevated fasting glucose and/or elevated trigly-
ceride groups respectively.
Participants with fasting glucose ≥100 mg/dL and
<126 mg/dL, not meeting the criteria for diabetes, were
identified as having impaired fasting glucose [24]. Cri-
teria for diabetes were the following: fasting glucose
concentration ≥126 mg/dL; treatment for diabetes; or
plasma HbA1c ≥7% [25].
Statistical analysis
Prevalences and their 95% confidence intervals (CIs) were
calculated for MS and each of its components. Prevalence
estimates were standardised by age using the European
standard population. A Wald test was used to test the
significance of the differences observed between centrally
obese and non-centrally obese subjects in terms of aware-
ness of obesity as a health risk and associated lifestyles.
For this purpose central obesity was defined with the
high waist-circumference cut-off points (≥102 cm for
men and ≥88 cm for women). All statistical analyses
were performed using the STATA 10.0 software package
(Stata Corporation, College Station, TX, USA).
Results
Of the 2562 people invited to participate in the study,
61% agreed to give a fasting blood sample, yielding a
final sample of 1555 (718 men and 837 women). The
age and sex distribution of the sample was similar to
that of the general population of the Murcia Region.
The main characteristics of the study population are
shown in Table 1. While men displayed a worse profile
than did women in terms of glucose status, lipids and
smoking, women had a lower educational level and
engaged in less physical activity.
Table 2 shows the prevalence of MS and each of its
components across categories of sex, age, residence, edu-
cation and glucose status. Prevalence of MS varied from
27.2% (95%CI: 25.2-29.2) to 32.2% (95%CI: 30.1-34.3) and
33.2% (95%CI: 31.2-35.3), according to the R-ATPIII, IDF
and JIS94/80 respectively. Whereas the prevalence of MS
according to the IDF and JIS94/80 definitions increased
with age to a figure of approximately 60% in persons aged
70 years and over, prevalence of R-ATPIII MS seemed to
increase until age 60 years and then stabilise at around
53% in persons aged 60 years and over. The most com-
mon cardiovascular risk factors and components of MS in
our population were hypertension (46.6%) and central
obesity (40.7% or 66.1%, according to high or low waist
circumference cut-off points respectively). Prevalence of
MS and each of its components increased markedly with
age (p for trend <0.001). Prevalence of MS based on any of
the three definitions, and prevalence of each of its compo-
nents were both higher in persons with little or no formal
education (51.7% R-ATPIII, 56.4% IDF and 57.3% JIS94/
80) and glucose disorders.
As can be seen from Figure 1, regardless of the defini-
tion used, prevalence of MS increased with age, except
for men aged 70 years and over, who registered a lower
estimated prevalence than did their counterparts in the
60-69 age group. As the IDF and JIS94/80 definitions
use lower waist-circumference cut-offs, the estimates of
MS prevalence with these definitions were higher in
each age and sex group than were the corresponding R-
ATPIII/JIS102/88 estimates, with these differences being
greater among men.
Figure 2 depicts the degree of awareness of the patho-
genic role of obesity and adherence to preventive
recommendations and adequate weight control.
Although most persons were aware that obesity
increased health risks, regular exercise was very unusual
(13.0% centrally obese, 27.2% non-centrally obese). The
proportion of women doing the recommended two and
a half hours of moderate/vigorous physical exercise
weekly was extremely low, both for centrally obese
(9.9%) and non-centrally obese subjects (19.8%), and
amounted to half the corresponding proportions among
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walking at least two hours per week, with practically no
difference between centrally obese and non-centrally
obese subjects. Frequency of eating the main dietary
components was similar among centrally obese and
non-centrally obese persons. Only 21% of men and 31%
of women reported eating vegetables more than once
daily, and 27% of men and 35% of women consumed
red meat less than twice per week. The proportion of
women following the recommended frequency of eating
fruit, fish and red meat proved slightly higher among
centrally obese than non-centrally obese persons. At the
opposite extreme, about 95% of persons used olive oil
daily, irrespective of sex or obese status.
Table 1 Characteristics of study subjects
Men Women Total p
(n = 718) (n = 837) (n = 1555)
Age (years), mean ± SD 47.2 ± 17.4 47.6 ± 18.0 47.4 ± 17.7 0.622
20-29% 18.8 18.8 18.8 0.799
30-39 21.6 22.5 22.1
40-49 17.8 16.5 17.1
50-59 13.7 13.9 13.8
60-69 14.2 12.5 13.3
70+ 13.9 15.9 15.0
Residence, %
Urban 74.0 76.9 75.6 0.172
Rural 26.0 23.1 24.4
Education, %
Little or no formal education 21.1 29.1 25.4 0.004
Primary 20.3 17.0 18.5
Secondary 39.1 35.6 37.2
University 19.6 18.3 18.9
Waist circumference (cm), mean ± SD 97.5 ± 10.8 87.3 ± 13.4 92.1 ± 13.3 <0.001
Systolic BP (mmHg), mean ± SD 134.4 ± 20.6 122.5 ± 24.0 128.0 ± 23.3 <0.001
Diastolic BP (mmHg), mean ± SD 80.4 ± 11.2 74.2 ± 10.3 77.0 ± 11.2 <0.001
Fasting glucose (mg/dl), mean ± SD 99.5 ± 29.8 93.4 ± 25.3 96.2 ± 27.6 <0.001
HDL-Cholesterol (mg/dl), mean ± SD 49.3 ± 11.2 59.6 ± 13.5 54.9 ± 13.5 <0.001
Triglycerides (mg/dl), mean ± SD 128.9 ± 111.2 92.5 ± 51.4 109.3 ± 86.4 <0.001
Glucose status, %
Normoglycaemia 68.0 78.7 73.8 <0.001
Impaired fasting glucose 19.5 11.7 15.3
Diabetes 12.5 9.6 10.9
Smoking, %
Non-smoker 46.3 65.4 56.6 <0.001
Ex-smoker 15.0 4.1 9.1
Current smoker 38.7 30.5 34.3
Leisure-time physical activity
Household chores (hours/week), mean ± SD 3.8 ± 6.4 22.9 ± 17.3 14.1 ± 16.5 <0.001
Walking (hours/week), mean ± SD 6.9 ± 7.3 5.9 ± 6.1 6.4 ± 6.7 0.003
Moderate/vigorous PA (hours/week), mean ± SD 1.9 ± 3.8 0.9 ± 2.2 1.4 ± 3.1 <0.001
SD: standard deviation. BP: Blood pressure. HDL: High-density lipoprotein. PA: Physical activity
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Elevated waist
circumference
102/88
1
Elevated waist
circumference
94/80
2
Elevated
triglycerides
Reduced
HDL-
cholesterol
Elevated
blood
pressure
Elevated
fasting
glucose
Metabolic
syndrome
R-ATPIII
Metabolic
syndrome
IDF
Metabolic
syndrome
JIS94/80
%% % % % % % % %
(95%CI) (95%CI) (95%CI) (95%CI) (95%CI) (95%CI) (95%CI) (95%CI) (95%CI)
Total
unadjusted
40.7 66.1 22.8 27.3 46.6 26.0 27.2 32.2 33.2
(38.6-42.7) (64.1-68.2) (20.8-24.7) (25.1-29.4) (44.6-48.6) (24.1-28.0) (25.2-29.2) (30.1-34.3) (31.2-35.3)
Total age-
adjusted
39.9 65.8 22.7 27.0 44.9 25.0 26.1 31.1 32.1
European
population
(37.8-42.0) (63.7-67.9) (20.7-24.7) (24.8-29.2) (42.8-47.0) (23.1-27.0) (24.1-28.2) (28.9-33.2) (29.9-34.2)
Sex
Men 33.8 63.7 29.0 23.7 57.7 32.0 28.2 36.9 38.9
(30.6-37.0) (60.5-66.9) (25.7-32.2) (20.6-26.8) (54.4-61.0) (29.0-35.1) (25.1-31.2) (33.6-40.2) (35.6-42.2)
Women 46.6 68.3 17.4 30.3 37.1 20.9 26.3 28.1 28.4
(44.0-49.2) (65.7-70.9) (15.1-19.8) (27.3-33.4) (34.8-39.5) (18.5-23.3) (23.8-28.9) (25.5-30.8) (25.8-31.0)
Age, years
20-29 10.7 27.8 8.2 16.8 16.5 3.8 3.4 6.2 6.2
(7.1-14.2) (22.8-32.9) (5.1-11.3) (12.6-21.0) (12.3-20.6) (1.6-5.9) (1.3-5.5) (3.4-9.0) (3.4-9.0)
30-39 22.3 53.7 20.7 25.4 23.1 8.7 12.5 18.1 19.2
(17.9-26.7) (48.4-58.9) (16.8-24.6) (20.8-30.0) (19.0-27.2) (5.8-11.7) (9.1-15.9) (14.2-22.1) (15.2-23.3)
40-49 33.8 69.6 22.2 26.3 38.3 22.9 21.1 29.5 30.2
(28.1-39.5) (63.9-75.2) (17.4-27.0) (21.1-31.5) (33.0-43.5) (18.2-27.7) (16.3-26.0) (24.3-34.8) (24.9-35.5)
50-59 59.2 85.0 31.3 30.4 58.0 35.5 37.4 39.6 42.1
(53.4-64.9) (80.4-89.6) (25.0-37.6) (24.1-36.7) (51.5-64.6) (29.2-41.9) (30.8-43.9) (33.0-46.3) (35.4-48.7)
60-69 71.4 92.2 32.4 37.7 80.2 49.8 53.6 57.8 58.9
(65.4-77.3) (88.7-95.7) (26.1-38.6) (31.4-44.0) (74.9-85.5) (42.9-56.6) (46.9-60.3) (51.0-64.5) (52.3-65.6)
70+ 69.3 88.6 28.3 32.2 88.7 53.2 52.6 59.6 60.3
(64.2-74.4) (84.6-92.6) (22.7-34.0) (26.4-38.0) (84.6-92.8) (47.0-59.5) (46.4-58.7) (53.5-65.8) (54.2-66.5)
Residence
Urban 39.7 64.9 21.7 26.9 45.0 25.3 26.1 30.7 31.7
(37.4-42.1) (62.5-67.3) (19.5-23.9) (24.4-29.4) (42.8-47.3) (23.1-27.5) (23.9-28.4) (28.4-33.1) (29.4-34.1)
Rural 43.5 69.9 26.1 28.4 51.6 28.4 30.5 36.8 37.9
(39.5-47.6) (66.0-73.8) (21.9-30.2) (24.1-32.7) (47.5-55.7) (24.3-32.5) (26.5-34.6) (32.4-41.1) (33.5-42.3)
Education
Little or no
formal
education
72.8 90.7 33.0 37.3 79.1 45.4 51.7 56.4 57.3
(68.7-76.8) (88.0-93.5) (28.4-37.5) (32.7-41.9) (75.2-83.0) (40.6-50.3) (46.8-56.5) (51.6-61.3) (52.4-62.1)
Primary 49.8 79.3 23.7 26.5 55.8 33.8 34.1 38.2 39.4
(44.1-55.5) (74.6-84.0) (18.8-28.6) (21.4-31.5) (50.2-61.4) (28.5-39.1) (28.7-39.6) (32.7-43.8) (33.8-44.9)
Secondary 25.2 53.4 18.4 25.1 29.4 13.7 14.4 20.0 21.2
(21.7-28.7) (49.4-57.4) (15.3-21.4) (21.6-28.7) (25.8-33.0) (11.0-16.4) (11.6-17.2) (16.8-23.2) (17.9-24.4)
University 19.6 45.7 16.7 18.4 28.5 16.7 12.7 18.6 18.8
(15.1-24.1) (40.2-51.2) (12.6-20.9) (14.0-22.9) (23.5-33.5) (12.6-20.8) (8.9-16.4) (14.2-22.9) (14.5-23.2)
Glucose status
Normoglycaemia 31.8 58.2 16.9 24.0 35.6 0.0 11.8 15.9 16.1
(29.4-34.2) (55.6-60.8) (14.8-19.0) (21.5-26.4) (33.1-38.1) (10.0-13.6) (13.9-18.0) (14.1-18.2)
Impaired fasting
glucose
61.3 87.7 34.5 31.5 73.3 100 66.2 76.5 78.9
(55.2-67.3) (83.5-91.9) (28.5-40.4) (25.6-37.5) (67.7-78.9) (60.3-72.2) (71.1-81.9) (73.8-84.0)
Gavrila et al. BMC Public Health 2011, 11:562
http://www.biomedcentral.com/1471-2458/11/562
Page 5 of 9Discussion
In the Murcia Region, one-third of the general popula-
tion aged 20 years and over met the IDF and JIS94/80
definitions for MS, which was slightly higher than the
proportion yielded by the R-ATPIII definition. The
crude and European population age-adjusted MS preva-
lence figures were very similar, namely, 27.2% vs. 26.1%,
32.2% vs. 31.1% and 33.2% vs. 32.1% according to the R-
ATPIII, IDF and JIS94/80 definitions respectively.
Our findings on the prevalence of MS are comparable to
those reported both by Qiao’s study [26] based on colla-
boratively analysed data from nine European cohort stu-
dies, and by other studies undertaken in Northern
European countries [27,28]. The prevalence in our study
was higher than that encountered by other studies con-
ducted in Australia [29], Russia [30], Italy [31] or even
other Spanish regions [32-34] in which it ranged from 15
to 22%. Even so, the prevalence estimated by us was lower
than that for the US population [35]. To a certain extent,
such differences in MS prevalence among studies are due
to differences in methodology and, more particularly, in
the measures of obesity used. A recent study by Vega et al.
[36] showed that prevalence of MS was influenced by the
measure of obesity used, and went on to question the
inclusion of any measure of obesity among the diagnostic
components of MS. The so-called abridged ATPIII MS -
defined as 3 of 4 independent risk factors after obesity is
removed from the diagnostic criteria - successfully identi-
fied a subgroup of patients who were at higher risk of car-
diovascular disease and were therefore candidates for
intensive cardiovascular risk reduction. Moreover, regard-
less of the definition used, MS identifies a group of sub-
jects at significantly greater coronary heart disease risk,
and the proportion of such higher-risk subjects is compar-
able regardless of whether the high or low waist-circum-
ference cut-off point is used, as was recently shown by
Alkerwi et al. [37]. In contrast, overweight and obesity
measured by reference to body mass index failed to detect
any increased cardiovascular risk in our population [6].
In agreement with Martínez-Candela’s study [34], con-
ducted on a similar population, and with the studies
undertaken by Halldin in Sweden [27], and Alkerwi in
Luxembourg [37], prevalence of MS was higher in men
than in women. This finding differs from other studies
which reported similar prevalences in both sexes
[28,35,38] or, on the contrary, a higher prevalence in
women then in men [30,31,33,39]. As with other studies,
prevalence of MS and of each of its components was
observed to increase with age and be higher among the
population with a low education level. The results of
our study are in line with several other studies [29,40]
that have reported a levelling-off or even a decline in
the prevalence of MS among men after the sixth or
seventh decade of life versus a linear increase with age
among women. This differen c em a yb ed u et os e l e c t i v e
survival with increased mortality rates among men in
general, and among those with metabolic risk factors in
particular.
Although most persons were aware of the pathogenic
role of obesity, only a small proportion reported physical
activity and dietary habits consistent with the preventive
recommendations for weight control. While the lowest
adherence to the dietary recommendations was found
for vegetables and red meat, the highest adherence was
found for olive oil. The food consumption patterns
reported by centrally obese and non-centrally obese
Table 2 Prevalence (%) of metabolic syndrome and its components according to the R-ATPIII, IDF and JIS94/80 criteria
(Continued)
Diabetes 72.3 90.4 45.9 43.5 84.0 98.2 76.9 81.9 85.2
(65.5-79.1) (85.9-94.8) 38.4-53.3) (36.2-50.9) (78.5-89.5) (96.3-100) (70.7-83.2) (76.1-87.8) (79.9-90.5)
R-ATPIII: Revised National Cholesterol Education Program Adult Treatment Panel III. IDF: International Diabetes Federation.
JIS 94/80: Joint Interim Statement with waist-circumference cut-off points of ≥94 cm for men and ≥80 cm for women
1Waist circumference ≥102 cm for men and ≥88 cm for women
2Waist circumference ≥94 cm for men and ≥80 cm for women
Figure 1 Prevalence and 95%CI of metabolic syndrome
according to the R-ATPIII, IDF and JIS94/80 definitions, by sex
and age groups. R-ATPIII: Revised National Cholesterol Education
Program Adult Treatment Panel III. JIS 94/80: Joint Interim Statement
with waist-circumference cut-off points of ≥94 cm for men and ≥80
cm for women. IDF: International Diabetes Federation.
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Page 6 of 9persons were very similar, except for the higher fre-
quency of fruit and fish intake and lower frequency of
red meat intake among centrally obese women.
Substantial differences in physical activity between the
centrally obese and non-centrally obese were observed
for men and women alike, with the proportion of non-
centrally obese persons doing the recommended physi-
cal activity being twice as high as the corresponding
proportion of centrally obese persons. This is in agree-
ment with Halldin et al’s study [27], which observed a
strong inverse dose-response association between lei-
sure-time physical activity and MS, and stressed the role
of physical activity in the prevention and treatment of
MS. Even in the non-centrally obese population, the
proportion of persons with an adequate frequency of
physical activity is excessively low, especially among
women. A possible explanation for the extremely low
proportion of women doing the recommended physical
activity could be the long hours that women devote to
household chores (an average of 23 hours per week for
women vs. 4 hours per week for men), which thus com-
petes with the time available for physical activity.
This study has several limitations. First, the 61%
blood-extraction response rate was less than desirable.
Nevertheless, as the sex- and age-distribution of the
sample was similar to that of the general population,
selection bias can be assumed to be minimal. Secondly,
while the use of a food-frequency questionnaire without
any quantitative or semi-quantitative measure hinders
the assessment of energy intake, an important factor in
Without central obesity
With central obesity       Men                              Women
62.2%
54.9%
95.1%
95.1%
27.8%
26.2%
55.6%
54.6%
65.0%
65.0%
24.2%
20.2%
54.3%
47.6%
74.4%
75.8%
17.6%
16.8%
17.8%
34.1%
96.0%
96.2%
75.6%
80.6%
27.2%
24.6%
96.8%
96.5%
43.0%
29.2%
63.7%
57.0%
60.1%
66.7%
30.0%
31.2%
59.0%
46.6%
60.3%
58.5%
9.4%
11.3%
9.9%
19.8%
94.7%
94.5%
89.8%
90.3%
100% 75% 50% 25% 0% 25% 50% 75% 100%
Wine min . 1/week - max. 1-3/day†
Olive oil ≥1/day
Red meat <2/week
Fish >1/week
Legumes >1/week
Vegetables >1/day
Fruits >1/day
Cereals >1/day
Walking ≥2h/week
Physical activity ≥ 2½ h/week
Awareness assoc. obesity-diabetes/MI
Awareness of obesity as a disease
**
**
**
**
*
*
Figure 2 Awareness of the pathogenic role of obesity and adherence to preventive recommendations for adequate weight control.
Central obesity was defined with the high waist-circumference cut-off points (≥102 cm for men and ≥88 cm for women).
aWine intake from a
minimum of 1/week until a maximum of 3/day in men and 1/day in women. * p < 0.05. ** p < 0.01.
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Page 7 of 9the appearance and maintenance of obesity, it neverthe-
less allows for comparison with the Mediterranean diet
pyramid [20]. Thirdly, due to the study’s cross-sectional
design, the dietary pattern observed in the centrally
obese population may, to a certain extent, reflect
changes in diet introduced as a result of medical advice.
Finally, a misreporting bias cannot be ruled out, since
obese subjects are known to be prone to overestimate
their adherence to healthy lifestyles, e.g., by underre-
porting their energy intake and overreporting their
intake of fruit and vegetables [41].
The strengths of our study include the fact that it bene-
fits from being a population-based study covering a wide
age range, and that prevalence of MS was estimated in
accordance with the latest, most widely used definitions.
Moreover, by examining both degree of awareness of the
pathogenic role of obesity and adherence to preventive
recommendations and adequate weight control, we were
able to identify the discrepancy between the high degree
of awareness and its low impact on improving adherence
to healthier lifestyles. The study was based on the most
recent data on cardiovascular risk factors available in our
region and provides valuable information for decision-
makers with regard to areas of health promotion that
should be reinforced. Measures targeted at improving
adherence to preventive recommendations and adequate
weight promotion are required in both sexes, with special
stress on dietary recommendations in men and increased
physical activity in women.
Further studies are called for to assess trends in cardi-
ovascular risk factor prevalence and changes in lifestyles
in our region, and their impact on risk of coronary
heart disease. Using a low cut-off point for waist cir-
cumference identifies more persons who need interven-
t i o n ;a n d ,a st h i sm i g h tp r o v ee x c e s s i v e ,f u r t h e rs t u d i e s
are needed to ascertain which waist-circumference cut-
off point would be more appropriate for our population.
Similarly, longitudinal studies are warranted to assess
the impact of MS and abdominal obesity on cardiovas-
cular risk among the local population.
Conclusions
The prevalence of MS is high in our population, is com-
parable to that found in northern Europe, and varies with
the definition used. Adherence to preventive recommen-
dations and adequate weight promotion is very low. In
the absence of a specific treatment for MS, integrated
intervention based on a sustained increase of physical
activity and changes in diet should be reinforced.
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